CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
Platelet Rich Plasma +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01765712
NCT01765712Phase 4Completed

"Effect of Intraoperative Application of Autologous PRP on Post Operative Morbidity in ACL Reconstruction Using Autologous Bone Patellar Tendon Bone Graft Harvest"

Brian Walters·interventional·Posted Jan 10, 2013·Updated Mar 24, 2021

In Brief

A Phase 4 clinical trial evaluating Anterior Cruciate ligament reconstruction bone patellar tendon bone autograft and Platelet Rich Plasma for Post Operative Pain. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this research study is to investigate whether or not platelet rich plasma (PRP) may help to improve tendon healing and decrease post operative pain in patients undergoing anterior cruciate ligament (ACL) reconstructive surgery using their own patellar tendons as autografts.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2013
Enrollment StartDec 1, 2012
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 13.5 years ago

Interventions

Anterior Cruciate ligament reconstruction bone patellar tendon bone autograftprocedure

Platelet Rich Plasmabiological